As of Jun 27
| +0.06 / +0.45%|
The 4 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 13.75, with a high estimate of 16.00 and a low estimate of 12.00. The median estimate represents a +1.85% increase from the last price of 13.50.
The current consensus among 5 polled investment analysts is to Hold stock in AngioDynamics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.